The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Fekete, M.,
Lehoczki, A.,
Szappanos, Á.,
Tóth, A.,
Mahdi, M.,
Sótonyi, P.,
Benyó, Z.,
Yabluchanskiy, A.,
Tarantini, S.,
Ungvári, Z.:
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.
GeroScience. [Epub ahead of print], 2025.
Mahdi, M.,
Srivastava, V.:
Editorial: Cellular and host immune responses in the context of dual viral infection.
Front. Immunol. 16, 1-2, (article identifier: 1641084), 2025.
Kiarie, I. W.,
Hoffka, G.,
Laporte, M.,
Leyssen, P.,
Neyts, J.,
Tőzsér, J.,
Mahdi, M.:
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.
Viruses-Basel. 16 (10), 1-15, (article identifier: 1607), 2024.
Papp, H.,
Tóth, E.,
Bóvári-Biri, J.,
Bánfai, K.,
Juhász, P.,
Mahdi, M.,
Russo, L. C.,
Bajusz, D.,
Sipos, A.,
Petri, L.,
Szalai, T. V.,
Kemény, Á.,
Madai, M.,
Kuczmog, A.,
Batta, G.,
Mózner, O.,
Vaskó, D.,
Hirsch, E.,
Bohus, P.,
Méhes, G.,
Tőzsér, J.,
Curtin, N.,
Helyes, Z.,
Tóth, A.,
Hoch, N. C.,
Jakab, F.,
Keserű, G. M.,
Pongrácz, J.,
Bai, P.:
The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
Bakos, I.,
Mahdi, M.,
Kardos, L.,
Nagy, A.,
Várkonyi, I.:
Clinical Spectrum and CSF Findings in Patients with West-Nile Virus Infection, a Retrospective Cohort Review.
Diagnostics. 12 (4), 1-9, (article identifier: 805), 2022.
Mótyán, J. A.,
Mahdi, M.,
Hoffka, G.,
Tőzsér, J.:
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: lessons Learned from HIV-1 Protease.
Int. J. Mol. Sci. 23 (7), 1-20, (article identifier: 3507), 2022.
Mahdi, M.,
Hermán, L.,
Réthelyi, J.,
Bálint, B. L.:
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
Int. J. Mol. Sci. 23 (7), 1-21, (article identifier: 3812), 2022.
Golda, M.,
Mótyán, J. A.,
Mahdi, M.,
Tőzsér, J.:
Functional Study of the Retrotransposon-Derived Human PEG10 Protease.
Int. J. Mol. Sci. 21 (7), 1-22, (article identifier: 2424), 2020.
Szojka, Z.,
Mótyán, J. A.,
Miczi, M.,
Mahdi, M.,
Tőzsér, J.:
Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.
Int. J. Mol. Sci. 21 (16), 1-17, (article identifier: 5907), 2020.
Csősz, É.,
Tóth, F.,
Mahdi, M.,
Tsaprailis, G.,
Emri, M.,
Tőzsér, J.:
Analysis of networks of host proteins in the early time points following HIV transduction.
BMC Bioinformatics. 20, 1-18, (article identifier: 398), 2019.
Constantin, T.,
Rákóczi, É.,
Ponyi, A.,
Ambrus, C.,
Kádár, K.,
Vastagh, I.,
Dajnoki, A.,
Lajszné Tóth, B.,
Bokrétás, G.,
Müller, V.,
Katona, M.,
Csíkós, M.,
Fiedler, O.,
Széchey, R.,
Varga, E.,
Rudas, G.,
Kertész, A. B.,
Molnár, S.,
Kárpáti, S.,
Nagy, V.,
Magyar, P.,
Mahdi, M.,
Németh, K.,
Bereczki, D.,
Garami, M.,
Erdős, M.,
Maródi, L.,
Fekete, G.:
Fabry-betegség: diagnosztikai útmutató.
Orv. Hetil. 151 (7), 243-249, 2010.